Community-acquired Bacterial Pneumonia
📧 Sign up to get email alerts when something new happens for Community-acquired Bacterial Pneumonia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2013-02-11Clinical Trial Update: Safety and Efficacy Study of Ceftaroline in Elderly Subjects With Community-Acquired Bacterial Pneumonia [Phase 4]
This report notes that a Phase 4 safety and efficacy trial of ceftaroline for elderly patients with community-acquired bacterial pneumonia h…
-
FDA approval · 2011-06-29FDA Approved: TEFLARO — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for TEFLARO (ceftaroline fosamil) submitted by Allergan, Inc., under NDA 200327.
-
FDA approval · 2011-03-11FDA Approved: TEFLARO — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for TEFLARO (ceftaroline fosamil) submitted by Allergan, Inc. The action confirms regulatory app…
-
FDA label_change · 2007-01-24FDA Approved: TYGACIL — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for TYGACIL (tigecycline) submitted by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., to up…